We are live on ! Find out more
GRNA

GreenLight Biosciences Holdings, PBC Common Stock
GRNA

Delisted

GRNA was delisted on the 21st of July, 2023.

Back to rankings

54 hedge funds and large institutions have $134M invested in GreenLight Biosciences Holdings, PBC Common Stock in 2021 Q2 according to their latest regulatory filings, with 23 funds opening new positions, 11 increasing their positions, 3 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

2,200% more first-time investments, than exits

New positions opened: 23 | Existing positions closed: 1

267% more repeat investments, than reductions

Existing positions increased: 11 | Existing positions reduced: 3

69% more funds holding

Funds holding: 32 → 54 (+22)

40% more capital invested

Capital invested by funds: $95.9M → $134M (+$37.9M)

Holders
54
Holders Change
+22
Holders Change %
+68.75%
% of All Funds
0.94%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
23
Increased
11
Reduced
3
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
AC
Aristeia Capital
Connecticut
+$6.29M
2
HCM
Highbridge Capital Management
New York
+$4.53M
3
Alyeska Investment Group
Alyeska Investment Group
Illinois
+$3.41M
4
Bank of Montreal
Bank of Montreal
Ontario, Canada
+$3.4M
5
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Ontario, Canada
+$3.17M

Top Sellers

Rank Fund Capital Flow
1
UOC
UBS O'Connor
Illinois
-$3.4M
2
TCM
Tuttle Capital Management
Connecticut
-$280K
3
UBS Group
UBS Group
Switzerland
-$51.5K
4
TCM
Tenor Capital Management
New York
-$36.1K
Name Holding Trade Value Shares
Change 		Change in
Stake
AA
26
AQR Arbitrage
Connecticut
$1.5M +$1.49M +153,181 New
TCM
27
Tenor Capital Management
New York
$1.44M -$36.1K -3,700 -2%
CL
28
CSS LLC
Illinois
$1.38M +$616K +63,213 +81%
Nomura Holdings
29
Nomura Holdings
Japan
$1.28M +$505K +51,841 +65%
KC
30
Kepos Capital
New York
$1.26M +$1.25M +128,498 New
AFM
31
Anson Funds Management
Texas
$1.23M – – –
NM
32
Newtyn Management
New York
$1.23M – – –
VI
33
Vestcor Inc
New Brunswick, Canada
$1.1M – – –
Toronto Dominion Bank
34
Toronto Dominion Bank
Ontario, Canada
$1.02M +$1.01M +104,086 New
RCM
35
Radcliffe Capital Management
Pennsylvania
$880K +$875K +89,754 New
AIMCA
36
Alberta Investment Management Corp (AIMCo)
Alberta, Canada
$564K +$561K +57,500 New
NAM
37
Nexpoint Asset Management
Texas
$539K +$536K +54,979 New
CM
38
Crestline Management
Texas
$507K +$390K +40,000 +342%
DAM
39
Deltec Asset Management
New York
$490K – – –
ACA
40
Arena Capital Advisors
California
$475K +$472K +48,413 New
Millennium Management
41
Millennium Management
New York
$469K +$466K +47,835 New
KKRC
42
Kohlberg Kravis Roberts & Co
New York
$414K +$218K +22,319 +112%
SSA
43
Schonfeld Strategic Advisors
New York
$411K +$213K +21,879 +109%
CC
44
Centiva Capital
New York
$294K +$292K +30,000 New
Geode Capital Management
45
Geode Capital Management
Massachusetts
$181K +$181K +18,521 New
WAM
46
Wolverine Asset Management
Illinois
$179K +$105K +10,747 +143%
LCM
47
Landscape Capital Management
New Jersey
$140K +$139K +14,275 New
PC
48
Periscope Capital
Ontario, Canada
$119K +$118K +12,141 New
Rockefeller Capital Management
49
Rockefeller Capital Management
New York
$98K +$97.5K +10,000 New
UBS Group
50
UBS Group
Switzerland
$50K -$51.5K -5,280 -51%
1
2
3

GRNA Hedge Fund Activity: Q2 2021 in Review

54 of the 5,746 institutional investors tracked by Wall St. Rank reported a position in GreenLight Biosciences Holdings, PBC Common Stock (GRNA) for Q2 2021, worth a combined $134M — up 40% from $95.9M a quarter earlier.

Buyers outnumbered sellers: 23 funds opened new GRNA positions and 1 closed out — a net gain of 22 holders — while 11 added to existing stakes and 3 trimmed.

The largest buyer was Aristeia Capital, opening a new position worth an estimated $6.29M. The largest seller was UBS O'Connor, cutting an estimated $3.4M.

  • 54 institutional investors held GreenLight Biosciences Holdings, PBC Common Stock (GRNA) as of Q2 2021, up from 32 in Q1 2021.
  • Funds reported $134M of GreenLight Biosciences Holdings, PBC Common Stock stock for Q2 2021, up 40% quarter-over-quarter.
  • 23 funds opened new GreenLight Biosciences Holdings, PBC Common Stock positions in Q2 2021 and 1 closed out, a net change of +22 holders.
  • The largest GreenLight Biosciences Holdings, PBC Common Stock buyer in Q2 2021 was Aristeia Capital, an estimated $6.29M added.
  • The largest GreenLight Biosciences Holdings, PBC Common Stock seller in Q2 2021 was UBS O'Connor, an estimated $3.4M sold.

Based on aggregated 13F filings for Q2 2021.